Ledger.Open graph →
SEC Form D · Amendment · filed November 12, 2019

CytoDyn Inc

Offering
$20.0M
Sold
$7.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
VANCOUVER, WA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Michael D. Mulholland · Vancouver, WAExecMichael A. Klump · Vancouver, WADirectorDavid F. Welch · Vancouver, WADirectorScott A. Kelly · Vancouver, WADirectorNader Z. Pourhassan · Vancouver, WAExec · DirectorJordan G. Naydenov · Vancouver, WADirectorNikesh Arora · Palo Alto, CADirectorZachary Dexter · MIAMI, FLExec · DirectorBuligo Capital Partners Limited · Wilmington, DEExecJames Wo · MIAMI, FLDirectorTerente Culver · MIAMI, FLDirectorPaul Kotos · MIAMI, FLDirectorYuriy Gelfman · New York, NYDirectorIan Bel · New York, NYExecAlan Shvetz · New York, NYExec · DirectorMichael Rosenfeld · New York, NYDirectorLeah Brownlee · Cleveland, OHDirectorEugene Malinskiy · Cleveland, OHDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗